First-of-its-kind lab at U of I aims to treat chronic diseases, develop new cellular therapies

First-of-its-kind lab at U of I aims to treat chronic diseases, develop new cellular therapies

(WCIA) — A new laboratory at the University of Illinois is one of very few throughout the world to combine cancer treatment and regenerative medicine in the same space. The Translational Oncology and Regenerative Medicine Laboratory will be based at the Beckman Institute and led by CI MED Dean Mark Cohen, MD.

Source: WCIA

Indexed: Mon, 22 Jun 2026 22:27:57 UTC

Not a government entity. Not a broker or agent. Public information index only. Verify independently.

Bir yanıt yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir